Company news

Pulmatrix, Inc. news in 2026

Pulmatrix, Inc.'s news releases, calls and decks from 2026, newest first.

View company

Eos SENOLYTIX Reports Interim Data Showing Preserved Physical Function with MitoXcel Geropeptide PTC-2105 in a Second Species, Aged-Rat Study

October 30, 2026

Eos SENOLYTIX Presents Late-Life Survival and Healthspan Data for Mitochondria-Targeted Geropeptide PTC-2105 at the 17th World Congress on Targeting Mitochondria, and Launches “Team Speedy” to Let the Public Follow Its Longest-Lived Mouse

October 22, 2026

Pulmatrix Announces Second Quarter 2026 Financial Results and Progress on Merger

August 13, 2026

Pulmatrix Announces First Quarter 2026 Financial Results

May 15, 2026

Pulmatrix Announces Closing of Preferred Stock Transaction as Part of Planned Merger

April 21, 2026

Pulmatrix and Eos SENOLYTIX Announce Merger Agreement to Advance Novel Mitochondrial Therapies to Improve Healthspan

March 25, 2026

Pulmatrix Announces Termination of Prior Planned Merger and Continues Pursuit of Alternative Merger Opportunities

March 1, 2026

Pulmatrix Announces Year-End and Fourth Quarter 2025 Financial Results

February 26, 2026

Decks in 2026